vs

Side-by-side financial comparison of SANFILIPPO JOHN B & SON INC (JBSS) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

SANFILIPPO JOHN B & SON INC is the larger business by last-quarter revenue ($314.8M vs $221.4M, roughly 1.4× UNIVERSAL TECHNICAL INSTITUTE INC). SANFILIPPO JOHN B & SON INC runs the higher net margin — 5.7% vs 0.2%, a 5.5% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (6.7% vs 4.6%). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (11.7% CAGR vs 7.6%).

John B. Sanfilippo & Son Inc. (JBSS) is a leading US processor, marketer and distributor of high-quality tree nuts, peanuts, dried fruits, and value-added snack products. It serves retail, foodservice, and industrial ingredient customers primarily across North America, offering both branded and private label product lines.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

JBSS vs UTI — Head-to-Head

Bigger by revenue
JBSS
JBSS
1.4× larger
JBSS
$314.8M
$221.4M
UTI
Growing faster (revenue YoY)
UTI
UTI
+2.2% gap
UTI
6.7%
4.6%
JBSS
Higher net margin
JBSS
JBSS
5.5% more per $
JBSS
5.7%
0.2%
UTI
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
11.7%
7.6%
JBSS

Income Statement — Q2 FY2026 vs Q2 FY2026

Metric
JBSS
JBSS
UTI
UTI
Revenue
$314.8M
$221.4M
Net Profit
$18.0M
$433.0K
Gross Margin
18.8%
Operating Margin
8.3%
0.2%
Net Margin
5.7%
0.2%
Revenue YoY
4.6%
6.7%
Net Profit YoY
32.1%
-60.5%
EPS (diluted)
$1.53
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JBSS
JBSS
UTI
UTI
Q1 26
$221.4M
Q4 25
$314.8M
$220.8M
Q3 25
$298.7M
$222.4M
Q2 25
$269.1M
$204.3M
Q1 25
$260.9M
$207.4M
Q4 24
$301.1M
$201.4M
Q3 24
$276.2M
$196.4M
Q2 24
$269.6M
$177.5M
Net Profit
JBSS
JBSS
UTI
UTI
Q1 26
$433.0K
Q4 25
$18.0M
$12.8M
Q3 25
$18.7M
$18.8M
Q2 25
$13.5M
$10.7M
Q1 25
$20.2M
$11.4M
Q4 24
$13.6M
$22.2M
Q3 24
$11.7M
$18.8M
Q2 24
$10.0M
$5.0M
Gross Margin
JBSS
JBSS
UTI
UTI
Q1 26
Q4 25
18.8%
Q3 25
18.1%
Q2 25
18.1%
Q1 25
21.4%
Q4 24
17.4%
Q3 24
16.9%
Q2 24
18.5%
Operating Margin
JBSS
JBSS
UTI
UTI
Q1 26
0.2%
Q4 25
8.3%
7.1%
Q3 25
9.0%
11.2%
Q2 25
7.5%
6.9%
Q1 25
10.8%
8.1%
Q4 24
6.4%
13.6%
Q3 24
6.2%
13.3%
Q2 24
5.4%
4.2%
Net Margin
JBSS
JBSS
UTI
UTI
Q1 26
0.2%
Q4 25
5.7%
5.8%
Q3 25
6.3%
8.4%
Q2 25
5.0%
5.2%
Q1 25
7.7%
5.5%
Q4 24
4.5%
11.0%
Q3 24
4.2%
9.6%
Q2 24
3.7%
2.8%
EPS (diluted)
JBSS
JBSS
UTI
UTI
Q1 26
$0.01
Q4 25
$1.53
$0.23
Q3 25
$1.59
$0.33
Q2 25
$1.15
$0.19
Q1 25
$1.72
$0.21
Q4 24
$1.16
$0.40
Q3 24
$1.00
$0.35
Q2 24
$0.85
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JBSS
JBSS
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$2.4M
$162.0M
Total DebtLower is stronger
$28.8M
$127.8M
Stockholders' EquityBook value
$370.1M
$339.9M
Total Assets
$617.7M
$852.2M
Debt / EquityLower = less leverage
0.08×
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JBSS
JBSS
UTI
UTI
Q1 26
$162.0M
Q4 25
$2.4M
$162.8M
Q3 25
$714.0K
$169.1M
Q2 25
$585.0K
$70.7M
Q1 25
$1.3M
$96.0M
Q4 24
$336.0K
$172.0M
Q3 24
$442.0K
$161.9M
Q2 24
$484.0K
$115.5M
Total Debt
JBSS
JBSS
UTI
UTI
Q1 26
$127.8M
Q4 25
$28.8M
$101.4M
Q3 25
$29.8M
$87.1M
Q2 25
$14.6M
$73.8M
Q1 25
$5.8M
$94.4M
Q4 24
$6.0M
$120.1M
Q3 24
$6.2M
$125.7M
Q2 24
$6.4M
$137.3M
Stockholders' Equity
JBSS
JBSS
UTI
UTI
Q1 26
$339.9M
Q4 25
$370.1M
$335.9M
Q3 25
$362.8M
$328.1M
Q2 25
$360.7M
$306.8M
Q1 25
$346.6M
$293.9M
Q4 24
$325.6M
$280.0M
Q3 24
$310.8M
$260.2M
Q2 24
$322.6M
$239.4M
Total Assets
JBSS
JBSS
UTI
UTI
Q1 26
$852.2M
Q4 25
$617.7M
$834.0M
Q3 25
$598.7M
$826.1M
Q2 25
$597.6M
$740.8M
Q1 25
$590.0M
$720.4M
Q4 24
$545.3M
$753.8M
Q3 24
$519.4M
$744.6M
Q2 24
$515.6M
$706.0M
Debt / Equity
JBSS
JBSS
UTI
UTI
Q1 26
0.38×
Q4 25
0.08×
0.30×
Q3 25
0.08×
0.27×
Q2 25
0.04×
0.24×
Q1 25
0.02×
0.32×
Q4 24
0.02×
0.43×
Q3 24
0.02×
0.48×
Q2 24
0.02×
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JBSS
JBSS
UTI
UTI
Operating Cash FlowLast quarter
$62.5M
$7.1M
Free Cash FlowOCF − Capex
$40.0M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
7.1%
Cash ConversionOCF / Net Profit
3.48×
16.33×
TTM Free Cash FlowTrailing 4 quarters
$32.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JBSS
JBSS
UTI
UTI
Q1 26
$7.1M
Q4 25
$62.5M
$3.1M
Q3 25
$32.1M
$57.1M
Q2 25
$36.5M
$18.1M
Q1 25
$-25.9M
$-789.0K
Q4 24
$11.0M
$23.0M
Q3 24
$8.9M
$67.5M
Q2 24
$35.2M
$10.0M
Free Cash Flow
JBSS
JBSS
UTI
UTI
Q1 26
Q4 25
$40.0M
$-19.2M
Q3 25
$7.3M
$40.6M
Q2 25
$23.0M
$6.8M
Q1 25
$-37.6M
$-11.7M
Q4 24
$-2.7M
$19.6M
Q3 24
$-3.0M
$60.0M
Q2 24
$24.4M
$3.0M
FCF Margin
JBSS
JBSS
UTI
UTI
Q1 26
Q4 25
12.7%
-8.7%
Q3 25
2.4%
18.3%
Q2 25
8.6%
3.4%
Q1 25
-14.4%
-5.7%
Q4 24
-0.9%
9.7%
Q3 24
-1.1%
30.6%
Q2 24
9.0%
1.7%
Capex Intensity
JBSS
JBSS
UTI
UTI
Q1 26
Q4 25
7.1%
10.1%
Q3 25
8.3%
7.4%
Q2 25
5.0%
5.5%
Q1 25
4.5%
5.3%
Q4 24
4.5%
1.7%
Q3 24
4.3%
3.8%
Q2 24
4.0%
4.0%
Cash Conversion
JBSS
JBSS
UTI
UTI
Q1 26
16.33×
Q4 25
3.48×
0.24×
Q3 25
1.72×
3.04×
Q2 25
2.70×
1.69×
Q1 25
-1.29×
-0.07×
Q4 24
0.81×
1.04×
Q3 24
0.77×
3.58×
Q2 24
3.52×
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JBSS
JBSS

Sales Channel Directly To Consumer$263.2M84%
Sales Channel Commercial Ingredients$28.0M9%
Sales Channel Contract Packaging$23.6M8%

UTI
UTI

Segment breakdown not available.

Related Comparisons